Filing Flows › Veru (VERU) › Recalls, complaints & regulation
Veru (VERU): clinical trials
Veru (VERU) beyond its filings: 1 active clinical trial.
Veru's latest quarter
Veru, Q4 FY24: revenue $6.7M (+72% year over year), operating margin -112.1%, net loss $8.5M, operating cash flow −$4.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Veru have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.